Prevalence and characteristics of Brazilians aged 50 and over that received a doctor’s diagnosis of COVID-19: the ELSI-COVID-19 initiative

• Main Author: James Macinko
• Publication Date: 2020
• Other Authors: Brayan V. Seixas, Natalia Oliveira Woolley, Fabiola Bof de Andrade, Maria Fernanda Lima-Costa
• Format: Article
• Language: eng; por
• Source: Cadernos de Saúde Pública
• Download full: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7455
• topic: COVID-19; Health Services for the Aged; Aged; Health of the Elderly; COVID-19; Serviços de Saúde para Idosos; Idoso; Saúde do Idoso

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over half a million deaths worldwide. Brazil has been particularly impacted, registering more than 1.3 million infections and 57,000 deaths by late June 2020. Aggregate numbers of cases are essential in modeling the epidemic and planning responses; however, more detailed analysis of risk factors associated with SARS-CoV-2 infection are needed. Our study provides an initial examination of characteristics associated with receiving a doctor’s diagnosis of COVID-19 among a nationally representative sample of Brazilians aged 50 and over. Data are derived from the second wave of the Brazilian Longitudinal Study of Aging (ELSI-Brazil) and a telephone follow-up survey to ELSI-Brazil participants, known as the ELSI-COVID-19 initiative. The telephone survey was conducted between 26 May and 8 June 2020. Results show that about 2.4% (n = 70) of the sample reported being told by a doctor they had COVID-19, however, only about half of these individuals (n = 37) reported receiving a diagnostic confirmation from viral testing (RT-PCR). Demographic factors (aged 50-60 years), socioeconomic factors (lower household income), health-related factors (obesity, three or more chronic conditions), and geography (living in the Northern region of the country) were positively associated with reporting a COVID-19 diagnosis. Despite the descriptive and preliminary nature of these findings, results reported here suggest the need for more targeted approaches to enhance personal protection and provide greater viral testing options, especially for older, sicker and more vulnerable adults in Brazil.